{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:39:30Z","timestamp":1785487170699,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Science and technology project of Hebei Province","award":["15277715D"],"award-info":[{"award-number":["15277715D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0502-9","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T13:17:54Z","timestamp":1488374274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["High levels of serum \u03b22-microglobulin predict severity of coronary artery disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Ling","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"issue":"12","key":"502_CR1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.295.12.1404","volume":"295","author":"H Hemingway","year":"2006","unstructured":"Hemingway H, McCallum A, Shipley M, Manderbacka K, Martikainen P, Keskimaki I. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA. 2006;295(12):1404\u201311.","journal-title":"JAMA"},{"issue":"2","key":"502_CR2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","volume":"168","author":"JA Finegold","year":"2013","unstructured":"Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168(2):934\u201345.","journal-title":"Int J Cardiol"},{"issue":"16","key":"502_CR3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","volume":"169","author":"JF Beltrame","year":"2009","unstructured":"Beltrame JF, Weekes AJ, Morgan C, Tavella R, Spertus JA. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med. 2009;169(16):1491\u20139.","journal-title":"Arch Intern Med"},{"issue":"9050","key":"502_CR4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"F Haverkate","year":"1997","unstructured":"Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349(9050):462\u20136.","journal-title":"Lancet"},{"issue":"9","key":"502_CR5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0002-9343(03)00183-9","volume":"114","author":"A Dibra","year":"2003","unstructured":"Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schuhlen H, Schomig A, Kastrati A. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med. 2003;114(9):715\u201322.","journal-title":"Am J Med"},{"issue":"7","key":"502_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","volume":"352","author":"C Kragelund","year":"2005","unstructured":"Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005;352(7):666\u201375.","journal-title":"N Engl J Med"},{"issue":"14","key":"502_CR7","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.105.550715","volume":"112","author":"G Ndrepepa","year":"2005","unstructured":"Ndrepepa G, Braun S, Niemoller K, Mehilli J, von Beckerath N, von Beckerath O, Vogt W, Schomig A, Kastrati A. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation. 2005;112(14):2102\u20137.","journal-title":"Circulation"},{"issue":"26","key":"502_CR8","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","volume":"361","author":"T Omland","year":"2009","unstructured":"Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361(26):2538\u201347.","journal-title":"N Engl J Med"},{"issue":"1","key":"502_CR9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2010.09.018","volume":"161","author":"G Ndrepepa","year":"2011","unstructured":"Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, Hosl K, Schulz S, Fusaro M, Pache J, et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J. 2011;161(1):68\u201375.","journal-title":"Am Heart J"},{"issue":"9","key":"502_CR10","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.139.9.3132","volume":"139","author":"D Gussow","year":"1987","unstructured":"Gussow D, Rein R, Ginjaar I, Hochstenbach F, Seemann G, Kottman A, Ploegh HL. The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J Immunol. 1987;139(9):3132\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"502_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.arrt.2003.11.003","volume":"10","author":"JF Winchester","year":"2003","unstructured":"Winchester JF, Salsberg JA, Levin NW. Beta-2 microglobulin in ESRD: an in-depth review. Adv Ren Replace Ther. 2003;10(4):279\u2013309.","journal-title":"Adv Ren Replace Ther"},{"issue":"4","key":"502_CR12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/003655400750044935","volume":"32","author":"H Ullum","year":"2000","unstructured":"Ullum H, Lepri AC, Katzenstein TL, Phillips AN, Skinhoj P, Gerstoft J, Pedersen BK. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis. 2000;32(4):371\u20136.","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"502_CR13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/BF00185604","volume":"71","author":"H Diem","year":"1993","unstructured":"Diem H, Fateh-Moghadam A, Lamerz R. Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase. Clin Investig. 1993;71(11):918\u201323.","journal-title":"Clin Investig"},{"issue":"4","key":"502_CR14","first-page":"594","volume":"9","author":"N Sadamori","year":"1995","unstructured":"Sadamori N, Mine M, Hakariya S, Ichiba M, Kawachi T, Itoyama T, Nakamura H, Tomonaga M, Hayashi K. Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia. Leukemia. 1995;9(4):594\u20137.","journal-title":"Leukemia"},{"issue":"1\u20132","key":"502_CR15","first-page":"225","volume":"334","author":"J Castro","year":"2003","unstructured":"Castro J, Jimenez-Alonso J, Sabio JM, Rivera-Civico F, Martin-Armada M, Rodriguez MA, Jaimez L, Castillo MJ, Sanchez-Roman J. Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjogren syndrome and Sjogren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta. 2003;334(1\u20132):225\u201331.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"502_CR16","first-page":"163","volume":"20","author":"M Bethea","year":"1990","unstructured":"Bethea M, Forman DT. Beta 2-microglobulin: its significance and clinical usefulness. Ann Clin Lab Sci. 1990;20(3):163\u20138.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"502_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1081\/JDI-120017475","volume":"25","author":"D Jovanovic","year":"2003","unstructured":"Jovanovic D, Krstivojevic P, Obradovic I, Durdevic V, Dukanovic L. Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail. 2003;25(1):123\u201333.","journal-title":"Ren Fail"},{"issue":"12","key":"502_CR18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","volume":"116","author":"AM Wilson","year":"2007","unstructured":"Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY, Zhang F, Beck KR, Olin JW, Fung ET, et al. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation. 2007;116(12):1396\u2013403.","journal-title":"Circulation"},{"issue":"3","key":"502_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1358863X08089276","volume":"13","author":"ET Fung","year":"2008","unstructured":"Fung ET, Wilson AM, Zhang F, Harris N, Edwards KA, Olin JW, Cooke JP. A biomarker panel for peripheral arterial disease. Vasc Med. 2008;13(3):217\u201324.","journal-title":"Vasc Med"},{"issue":"19","key":"502_CR20","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jacc.2009.08.090","volume":"55","author":"JP Cooke","year":"2010","unstructured":"Cooke JP, Wilson AM. Biomarkers of peripheral arterial disease. J Am Coll Cardiol. 2010;55(19):2017\u201323.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"502_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2012.11.055","volume":"111","author":"KT Nead","year":"2013","unstructured":"Nead KT, Zhou MJ, Caceres RD, Sharp SJ, Wehner MR, Olin JW, Cooke JP, Leeper NJ. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol. 2013;111(6):851\u20136.","journal-title":"Am J Cardiol"},{"issue":"7","key":"502_CR22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/gm169","volume":"2","author":"RL Prentice","year":"2010","unstructured":"Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh M, Wang P, Buson Busald T, Hsia J, et al. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Med. 2010;2(7):48.","journal-title":"Genome Med"},{"issue":"5","key":"502_CR23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1440-1797.2005.00475.x","volume":"10","author":"A Zumrutdal","year":"2005","unstructured":"Zumrutdal A, Sezer S, Demircan S, Seydaoglu G, Ozdemir FN, Haberal M. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis. Nephrology. 2005;10(5):453\u20138.","journal-title":"Nephrology"},{"issue":"4 Suppl","key":"502_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","volume":"51","author":"WG Austen","year":"1975","unstructured":"Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975;51(4 Suppl):5\u201340.","journal-title":"Circulation"},{"issue":"3","key":"502_CR25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.","journal-title":"Am J Cardiol"},{"issue":"1","key":"502_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2010.09.017","volume":"4","author":"S Garg","year":"2011","unstructured":"Garg S, Sarno G, Serruys PW, Rodriguez AE, Bolognese L, Anselmi M, De Cesare N, Colangelo S, Moreno R, Gambetti S, et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. JACC Cardiovasc Interv. 2011;4(1):66\u201375.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"502_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.thromres.2013.06.007","volume":"132","author":"G Campo","year":"2013","unstructured":"Campo G, Pavasini R, Pollina A, Tebaldi M, Ferrari R. Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes. Thromb Res. 2013;132(2):151\u20137.","journal-title":"Thromb Res"},{"issue":"12","key":"502_CR28","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.ATV.0000247249.82030.94","volume":"26","author":"G Campo","year":"2006","unstructured":"Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, et al. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol. 2006;26(12):2800\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"502_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0952-7915(92)90126-Y","volume":"4","author":"TJ Braciale","year":"1992","unstructured":"Braciale TJ. Antigen processing for presentation by MHC class I molecules. Curr Opin Immunol. 1992;4(1):59\u201362.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"502_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0272-6386(89)80119-2","volume":"13","author":"S Acchiardo","year":"1989","unstructured":"Acchiardo S, Kraus Jr AP, Jennings BR. Beta 2-microglobulin levels in patients with renal insufficiency. Am J Kidney Dis. 1989;13(1):70\u20134.","journal-title":"Am J Kidney Dis"},{"key":"502_CR31","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1046\/j.1523-1755.2001.59780172.x","volume":"78","author":"F Takayama","year":"2001","unstructured":"Takayama F, Miyazaki S, Morita T, Hirasawa Y, Niwa T. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients. Kidney Int Suppl. 2001;78:S172\u2013176.","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"502_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajh.2830200405","volume":"20","author":"R Alexanian","year":"1985","unstructured":"Alexanian R, Barlogie B, Fritsche H. Beta 2 microglobulin in multiple myeloma. Am J Hematol. 1985;20(4):345\u201351.","journal-title":"Am J Hematol"},{"issue":"4","key":"502_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mpo.2950080403","volume":"8","author":"EH Cooper","year":"1980","unstructured":"Cooper EH, Plesner T. Beta-2-microglobulin review: its relevance in clinical oncology. Med Pediatr Oncol. 1980;8(4):323\u201334.","journal-title":"Med Pediatr Oncol"},{"issue":"24","key":"502_CR34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM197512112932404","volume":"293","author":"JP Michalski","year":"1975","unstructured":"Michalski JP, Daniels TE, Talal N, Grey HM. Beta2 microglobulin and lymphocytic infiltration in Sjogren\u2019s syndrome. N Engl J Med. 1975;293(24):1228\u201331.","journal-title":"N Engl J Med"},{"issue":"6","key":"502_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1291\/hypres.28.505","volume":"28","author":"Y Saijo","year":"2005","unstructured":"Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, Kishi R. Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens Res. 2005;28(6):505\u201311.","journal-title":"Hypertens Res"},{"issue":"7","key":"502_CR36","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","volume":"112","author":"I Tzoulaki","year":"2005","unstructured":"Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005;112(7):976\u201383.","journal-title":"Circulation"},{"issue":"6917","key":"502_CR37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374.","journal-title":"Nature"},{"issue":"9","key":"502_CR38","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135\u201343.","journal-title":"Circulation"},{"issue":"5","key":"502_CR39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","volume":"59","author":"BC Astor","year":"2012","unstructured":"Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59(5):653\u201362.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"502_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MNH.0b013e32835fe5ad","volume":"22","author":"BC Astor","year":"2013","unstructured":"Astor BC, Shaikh S, Chaudhry M. Associations of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens. 2013;22(3):331\u20135.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"502_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/00365513.2011.558108","volume":"71","author":"J Kals","year":"2011","unstructured":"Kals J, Zagura M, Serg M, Kampus P, Zilmer K, Unt E, Lieberg J, Eha J, Peetsalu A, Zilmer M. beta2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. Scand J Clin Lab Invest. 2011;71(4):257\u201363.","journal-title":"Scand J Clin Lab Invest"},{"issue":"7","key":"502_CR42","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/STROKEAHA.110.600312","volume":"42","author":"J Amighi","year":"2011","unstructured":"Amighi J, Hoke M, Mlekusch W, Schlager O, Exner M, Haumer M, Pernicka E, Koppensteiner R, Minar E, Rumpold H, et al. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke. 2011;42(7):1826\u201333.","journal-title":"Stroke"},{"issue":"2","key":"502_CR43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archinternmed.2007.64","volume":"168","author":"S Shinkai","year":"2008","unstructured":"Shinkai S, Chaves PH, Fujiwara Y, Watanabe S, Shibata H, Yoshida H, Suzuki T. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch Intern Med. 2008;168(2):200\u20136.","journal-title":"Arch Intern Med"},{"issue":"3","key":"502_CR44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5414\/CN107689","volume":"80","author":"YS Liu","year":"2013","unstructured":"Liu YS, Wang X, Jiang WD, Huang ZW, Wang YM, Hao L, Xing JL, Wang L, Liu XX, Lounsbury P, et al. Circulating levels of beta2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart. Clin Nephrol. 2013;80(3):168\u201376.","journal-title":"Clin Nephrol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0502-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:23:20Z","timestamp":1719084200000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0502-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["502"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0502-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,1]]},"article-number":"71"}}